News & Views
SeQuant Acquired in Strategic Move
Jun 13 2008
product portfolio.
âWe are pleased to have made this acquisition. It offers Merck superb
opportunities for the future expansion of the chromatography businessâ said Klaus Bischoff, Head of Performance & Life Science Chemicals division at Merck. âBy acquiring SeQuant we are gaining access to a unique technology in the rapidly growing HILIC application segment for analytical and preparative purposes. This technology will enable us to develop and commercialise innovative products that meet the needs of
our customers,â he added. Renamed Merck SeQuant AB, the previous site and all employees of the former company have been retained.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark